Auden Mckenzie Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 49
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Auden Mckenzie General Information

Description

Developer of generic medicines. The company's product portfolio includes molecules in various dosage forms, for treatments across a broad spectrum of therapeutic areas.

Contact Information

Website
www.audenmckenzie.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Acquirer
Allergan
Primary Office
  • Mckenzie House
  • Bury street, Middlesex
  • Ruislip HA4 7TL
  • England, United Kingdom
+44 01895 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Auden Mckenzie Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Auden Mckenzie‘s full profile, request access.

Request a free trial

Auden Mckenzie Executive Team (3)

Name Title Board Seat Contact Info
Praveen Parepally Chief Technology Officer
Amit Patel Managing Director
Janit Patel Director, Business Development
To view Auden Mckenzie’s complete executive team members history, request access »

Auden Mckenzie Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial